Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Metastatic Disease Clinical Trial Setting

Known as: METASTATIC 
A clinical trial or treatment setting in which the therapy of interest is used to treat metastatic disease.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
CONTEXT Invasive bladder cancer is a frequently occurring disease with a high mortality rate despite optimal treatment. The… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2017
Highly Cited
2017
Abstract Background Previous analysis of COMBI-d (NCT01584648) demonstrated improved progression-free survival (PFS) and overall… Expand
  • figure 1
  • figure 1
  • figure 2
  • figure 2
  • table 1
Highly Cited
2015
Highly Cited
2015
BACKGROUND Prostate cancer (PCa) is the second most common disease among men worldwide. It is important to know survival outcomes… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2015
Highly Cited
2015
BACKGROUND Cabazitaxel, abiraterone acetate (AA), and enzalutamide have been approved for the treatment of patients with… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2015
Highly Cited
2015
Metastasis is a leading cause of mortality for osteosarcoma patients. The molecular pathological mechanism remains to be… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Highly Cited
2014
Highly Cited
2014
BACKGROUND Vismodegib, a first-in-class Hedgehog pathway inhibitor, was US Food and Drug Administration (FDA) approved for… Expand
  • figure 1
  • table I
  • table II
  • figure 2
  • figure 3
Highly Cited
2013
Highly Cited
2013
Multiclass brain tumor classification is performed by using a diversified dataset of 428 post-contrast T1-weighted MR images from… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Highly Cited
2012
Highly Cited
2012
PURPOSE We evaluated the feasibility of administering carboplatin as a radiosensitizer during craniospinal radiation therapy… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 4
Highly Cited
2004
Highly Cited
2004
CCI‐779 is an analog of the immunosuppressive agent, rapamycin, that has demonstrated activity against melanoma in preclinical… Expand
Highly Cited
2001
Highly Cited
2001
Little is known about the genetic regulation of medulloblastoma dissemination, but metastatic medulloblastoma is highly… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4